| P2093 | author name string | Nehra A | |
| | Moreland RB | |
| P2860 | cites work | Transforming growth factor beta in tissue fibrosis | Q28239292 |
| | Transforming growth factor-beta in disease: the dark side of tissue repair | Q35603155 |
| | Is colchicine effective in Peyronie's disease? A pilot study | Q39482557 |
| | Superoxide dismutase for therapeutic use: clinical experience, dead ends and hopes | Q39564943 |
| | Oxidative damage and fibrogenesis | Q41260212 |
| | Peyronie's disease is associated with Paget's disease of bone | Q41486756 |
| | An animal model of Peyronie's-like condition associated with an increase of transforming growth factor beta mRNA and protein expression. | Q43758174 |
| | The incidence of Peyronie's disease in Rochester, Minnesota, 1950 through 1984. | Q43901005 |
| | Structural alterations in the tunica albuginea of the penis: impact of Peyronie's disease, ageing and impotence. | Q46052096 |
| | Anatomy and strength of the tunica albuginea: its relevance to penile prosthesis extrusion | Q46149043 |
| | Collagenase versus placebo in the treatment of Peyronie's disease: a double-blind study | Q46329766 |
| | Peyronie's disease is associated with an increase in transforming growth factor-beta protein expression | Q46755198 |
| | The treatment of Peyronie's disease with tamoxifen | Q46941711 |
| | Is there a role of hypoxemia in penile fibrosis: a viewpoint presented to the Society for the Study of Impotence | Q47906440 |
| | Engineering analysis of penile hemodynamic and structural-dynamic relationships: Part I--Clinical implications of penile tissue mechanical properties. | Q52242822 |
| | The Anatomy of the Tunica Albuginea in the Normal Penis and Peyronie's Disease | Q56228662 |
| | Evaluation of conservative therapeutic approaches to Peyronie's disease (fibrotic induration of the penis) | Q67838292 |
| | Mechanisms of calcification in Peyronie's disease | Q70275096 |
| | Identification of an inherited form of Peyronie's disease with autosomal dominant inheritance and association with Dupuytren's contracture and histocompatibility B7 cross-reacting antigens | Q72112799 |
| | Penile vascular evaluation of men with Peyronie's disease | Q72673623 |
| | Intralesional interferon in the treatment of Peyronie's disease: a pilot study | Q73095964 |
| | Penile trauma: an etiologic factor in Peyronie's disease and erectile dysfunction | Q73708956 |
| | Immunologic findings in Peyronie's disease: a controlled study | Q73886364 |
| | Peyronie's disease: intralesional treatment with interferon alpha-2A and evaluation of the results by magnetic resonance imaging | Q73957484 |
| | Histological and ultrastructural alterations in an animal model of Peyronie's disease | Q74384473 |
| | Use of intralesional verapamil to dissolve Peyronie's disease plaque: a long-term single-blind study | Q74544970 |
| | Treatment of Peyronie's disease with potassium para-aminobenzoate (potaba) | Q78663002 |
| P433 | issue | 5 | |
| P921 | main subject | pathophysiology | Q1135939 |
| P304 | page(s) | 406-410 | |
| P577 | publication date | 2002-10-01 | |
| P1433 | published in | International Journal of Impotence Research | Q15749221 |
| P1476 | title | Pathophysiology of Peyronie's disease | |
| P478 | volume | 14 | |